| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.012 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |